The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
LANTana trial protocol: An open label, single arm, phase Ib study to evaluate the effect of pre-treatment with ASTX727 (a demethylating agent) followed by lutetium Lu 177 dotatate in patients with progressive, metastatic neuroendocrine neoplasias (NENs).
 
Rohini Sharma
Honoraria - Eisai; Roche Pharma AG
Speakers' Bureau - Eisai
Research Funding - AAA HealthCare; Boston Scientific; Incyte; TERUMO
 
Caroline Ward
No Relationships to Disclose
 
Mitesh Naik
No Relationships to Disclose
 
Saraih Khan
No Relationships to Disclose
 
Tara Barwick
No Relationships to Disclose
 
Maria Martinez
No Relationships to Disclose
 
Hooshang Izadi
No Relationships to Disclose
 
Eric O. Aboagye
No Relationships to Disclose